1.Comparison of the impact of applications of Targeted Transfusion Protocol and Massive Transfusion Protocol in trauma patients.
Shahram PAYDAR ; Hosseinali KHALILI ; Golnar SABETIAN ; Behnam DALFARDI ; Shahram BOLANDPARVAZ ; Mohammad Hadi NIAKAN ; Hamidreza ABBASI ; Donat R SPAHN
Korean Journal of Anesthesiology 2017;70(6):626-632
BACKGROUND: The current study assessed a recently developed resuscitation protocol for bleeding trauma patients called the Targeted Transfusion Protocol (TTP) and compared its results with those of the standard Massive Transfusion Protocol (MTP). METHODS: Per capita utilization of blood products such as packed red blood cells (RBCs), fresh frozen plasma (FFP), and platelet concentrates was compared along with mortality rates during two 6-month periods, one in 2011 (when the standard MTP was followed) and another in 2014 (when the TTP was used). In the TTP, patients were categorized into three groups based on the presence of head injuries, long bone fractures, or penetrating injuries involving the trunk, extremities, or neck who were resuscitated according to separate algorithms. All cases had experienced motor vehicle accidents and had injury severity scores over 16. RESULTS: No statistically significant differences were observed between the study groups at hospital admission. Per capita utilization of RBC (4.76 ± 0.92 vs. 3.37 ± 0.55; P = 0.037), FFP (3.71 ± 1.00 vs. 2.40 ± 0.52; P = 0.025), and platelet concentrate (1.18 ± 0.30 vs. 0.55 ± 0.18; P = 0.006) blood products were significantly lower in the TTP epoch. Mortality rates were similar between the two study periods (P = 0.74). CONCLUSIONS: Introduction of the TTP reduced the requirements for RBCs, FFP, and platelet concentrates in severely injured trauma patients.
Blood Platelets
;
Craniocerebral Trauma
;
Erythrocytes
;
Extremities
;
Fractures, Bone
;
Hemorrhage
;
Humans
;
Injury Severity Score
;
Mortality
;
Motor Vehicles
;
Neck
;
Plasma
;
Resuscitation
;
Wounds and Injuries
2.Getting patient blood management Pillar 1 right in the Asia-Pacific: a call for action.
Hairil Rizal ABDULLAH ; Ai Leen ANG ; Bernd FROESSLER ; Axel HOFMANN ; Jun Ho JANG ; Young Woo KIM ; Sigismond LASOCKI ; Jeong Jae LEE ; Shir Ying LEE ; Kar Koong Carol LIM ; Gurpal SINGH ; Donat R SPAHN ; Tae Hyun UM
Singapore medical journal 2020;61(6):287-296
Preoperative anaemia is common in the Asia-Pacific. Iron deficiency anaemia (IDA) is a risk factor that can be addressed under patient blood management (PBM) Pillar 1, leading to reduced morbidity and mortality. We examined PBM implementation under four different healthcare systems, identified challenges and proposed several measures: (a) Test for anaemia once patients are scheduled for surgery. (b) Inform patients about risks of preoperative anaemia and benefits of treatment. (c) Treat IDA and replenish iron stores before surgery, using intravenous iron when oral treatment is ineffective, not tolerated or when rapid iron replenishment is needed; transfusion should not be the default management. (d) Harness support from multiple medical disciplines and relevant bodies to promote PBM implementation. (e) Demonstrate better outcomes and cost savings from reduced mortality and morbidity. Although PBM implementation may seem complex and daunting, it is feasible to start small. Implementing PBM Pillar 1, particularly in preoperative patients, is a sensible first step regardless of the healthcare setting.